Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Prem Subramanian, MD, PhD
Department of Ophthalmology
University of Colorado School of Medicine
Anschutz Medical Campus
1675 Aurora Court, Mailstop F-731
Aurora, Colorado, United States
Prem S. Subramanian is the Professor of ophthalmology, neurology, and neurosurgery at University of Colorado School of Medicine Anschutz Medical Campus. He specializes in neuro-ophthalmology, with special interest in the treatment of thyroid eye disease, disorders that cause double-vision in adults, as well as orbital and skull base tumors. His clinical practice includes patients with all types of disorders of the optic nerve and orbit. He performs surgery for tumors of the orbit, thyroid exophthalmos, and strabismus.
Dr. Subramanian received his medical degree from Baylor College of Medicine, Houston, Texas followed by residency in ophthalmology from Walter Reed Army Medical Center, Washington, DC and fellowship in neuro-ophthalmology from Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. He has an experience in treating conditions like cranial nerve palsies, double vision, intracranial hypertension, multiple sclerosis, ophthalmology, optic nerve disease, orbital tumors, pseudotumor cerebri, skull base tumors, strabismus, thyroid eye disease, and venous sinus stenosis. His research interests include optic nerve regeneration, traumatic brain injury, and effects of diplopia on quality of life.
John Nguyen, MDDr. John Nguyen graduated summa cum laud...
Grading Severity and Activity in Thyroid Eye DiseasePurpose: Thyroid eye disease (TED) is a...
Thyroid Eye Disease and the Role of the TED SpecialistNot all people with thyroid disease have...
Pediatric Graves’ Disease: Controversies in ManagementBackground/Aims: Graves' disease (GD) i...
Andrew R. Harrison, MDAndrew R. Harrison, MD is an Associate P...
Hyperthyroid Patients Without Graves’ Orbitopathy are not at Increased Risk of Developing Glaucoma: A Nationwi...Purpose: Graves' disease (GD) and toxic...
Mycophenolate Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-Severe Graves’ Or...Background: European guidelines recomme...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.